Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Apyx Medical (APYX) Finished Goods (2017 - 2018)

Historic Finished Goods for Apyx Medical (APYX) over the last 2 years, with Q4 2018 value amounting to $1.1 million.

Apyx Medical's Finished Goods rose 1035.16% to $1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.1 million, marking a year-over-year increase of 1035.16%. This contributed to the annual value of $1.1 million for FY2018, which is 1035.16% up from last year.
As of Q4 2018, Apyx Medical's Finished Goods stood at $1.1 million, which was up 1035.16% from $1.0 million recorded in Q4 2017.
In the past 5 years, Apyx Medical's Finished Goods registered a high of $1.1 million during Q4 2018, and its lowest value of $1.0 million during Q4 2017.